Top Life Sciences Companies To Watch For 2014

Given that you clicked on this article, it seems safe to assume you either own stock in SVB Financial (NASDAQ: SIVB  ) or are considering buying shares in the near future. If so, then you've come to the right place. The table below reveals the nine most critical numbers that investors need to know about SVB Financial stock before deciding whether to buy, sell, or hold it.

SVB Financial is not your typical bank. Located in Northern California, it's the holding company for Silicon Valley Bank, a niche lender that focuses almost exclusively on companies in the technology, life sciences, and winery space. Think venture capital. "For nearly three decades," its website reads, "SVB Financial Group and its subsidiaries, including Silicon Valley Bank, have been dedicated to helping entrepreneurs succeed." And if its share-price performance is any indication, this model has succeeded. Over the past 10 years, the total return to shareholders has been 273%. For context, only a handful of banks exceeded the 100% mark over this same time period -- including JPMorgan Chase, Goldman Sachs, Wells Fargo, and PNC Financial -- and roughly half of the 100-plus banks I examined actually declined in value over the same time period.

Hot Managed Healthcare Stocks To Invest In Right Now: Ventas Inc. (VTR)

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The firm primarily invests in healthcare-related facilities including hospitals, skilled nursing facilities, senior housing facilities, medical office buildings, and other healthcare related facilities. Ventas, Inc. was founded in 1983 and is based in Chicago, Illinois with additional offices in Louisville, Kentucky and Dallas, Texas.

Advisors' Opinion:

• [By Brad Thomas]

  For current investors, I still think the recent 10% price reduction still represents a premium valuation - of mispriced risk - and I would consider a rotation into a more risk-aligned healthcare REIT like Healthcare Trust of America (HTA) yielding 4.82% or Ventas, Inc. (VTR) yielding 3.47%. (See my HTA article here and my VTR article here).

Top Life Sciences Companies To Watch For 2014: Fresnillo PLC (FRES)

Fresnillo plc is a silver and gold mining company. The Company, along with its subsidiaries, is engaged in the mining and beneficiation of non-ferrous minerals, and the sale of related production. The primary contents of this production include silver, gold, lead and zinc. The Company has six operating mines: the Fresnillo mine, located in the State of Zacatecas, which is primary silver mine; the Saucito mine, located in the State of Zacatecas, an underground silver mine; the Cienega mine, located in the State of Durango, an underground gold mine, including the San Ramon satellite mine; the Herradura mine, located in the State of Sonora, an open pit gold mine; the Soledad-Dipolos mine, located in the State of Sonora, an open pit gold mine, and the Noche Buena mine, located in State of Sonora, an open pit gold mine. Advisors' Opinion:

• [By Inyoung Hwang]

  Fresnillo (FRES), the world�� largest primary silver producer, surged 13 percent and Randgold, a producer of the precious metal in Africa, jumped 9.1 percent. Gold climbed to the highest price in almost two months and silver rose to the highest since May.

• [By Alexis Xydias]

  The FTSE All-Share Mining Index rose 3 percent. Randgold, a producer of the metal in Africa, advanced 6.8 percent to 4,722 pence. Fresnillo Plc (FRES), which operates silver and gold mines in Mexico, rallied 8.2 percent to 1,035 pence.

Top Life Sciences Companies To Watch For 2014: RBC Bearings Incorporated(ROLL)

RBC Bearings Incorporated manufactures and markets engineered precision plain, roller, and ball bearings primarily in North America, Europe, and Latin America. It operates in four segments: Plain Bearings, Roller Bearings, Ball Bearings, and Others. The Plain Bearings segment produces plain bearings with self-lubricating or metal-to-metal designs, including rod end bearings, spherical plain bearings, and journal bearings that are primarily used to rectify misalignments in various mechanical components. The Roller Bearings segment provides tapered roller bearings, needle roller bearings, and needle bearing track rollers and cam followers, which are anti-friction products that utilize cylindrical rolling elements. The Ball Bearings segment specializes in high precision aerospace, airframe control, thin section, and industrial ball bearings that utilize high precision ball elements to reduce friction in high speed applications. The Other segment consists of precision mechanic al components, which are used in various general industrial applications; and machine tool collets that are used for holding circular or rod-like pieces in a lathe or other machine. It serves construction and mining, oil and natural resource extraction, heavy truck, packaging, and semiconductor machinery; and aerospace and defense markets. The company offers its products through direct sales force and a network of industrial and aerospace distributors. RBC Bearings Incorporated is headquartered in Oxford, Connecticut.

Advisors' Opinion:

• [By Stephen Simpson, CFA]

  This is a logical deal for SKF on multiple fronts. For starters, Kaydon will meaningfully expand the company's U.S. presence - something it could have done on its own eventually, but certainly not without spending money. With that, there is the possibility of using Kaydon's existing U.S. footprint to sell more SKF products and further trouble rivals like RBC Bearings (ROLL) and ITT (ITT).

Top Life Sciences Companies To Watch For 2014: Bruker Corporation(BRKR)

Bruker Corporation designs, manufactures, services, and sells proprietary life science and materials research systems worldwide. The company?s Scientific Instruments segment offers advanced instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. Its Energy & Supercon Technologies segment provides superconducting materials, including metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications; and ceramic high temperature superconductors primarily for fusion energy research applications, as well as non-superconducting Cuponal materials and wires based on co-extruded copper and aluminum, and non-superconducting high technology tools. Its customers include companies in the medical industry; private and public research and development laboratories in the fields of fundamental and applied sciences, and energy research; academic institutions; and government agencies. This segment is also involved in the development of superconductors and superconducting-enabled devices for applications in power and energy, as well as industrial processing industries. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, M assachusetts.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Bruker (NASDAQ: BRKR) was down, falling 8.85 percent to $18.65 on Q3 results.

  Commodities
  In commodity news, oil traded down 0.93 percent to $95.48, while gold traded down 0.62 percent to $1,315.50.

• [By Charley Blaine]

  Scientific-instrument maker Bruker (NASDAQ: BRKR) was down, falling 6.18 percent to $19.19 on Q3 results.

  Commodities
  In commodity news, oil traded down 1.84 percent to $94.61. It was crude's lowest settlement since June 21. Crude had been up as much as 20.4 percent for the year; that's been trimmed to 3.4 percent. Gold settled down 0.8 percent to $1,313.20.

Top Life Sciences Companies To Watch For 2014: Chelsea Therapeutics International Ltd.(CHTP)

Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for the treatment of various human diseases. It is involved in developing Droxidopa, a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with primary autonomic failure and falls related to NOH in Parkinson?s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue syndrome, and freezing of gait in PD and down syndrome. The company intends to market its Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn?s disease, ankylosing spondylitis, uveitis, psoriatic arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The company?s molecule products include a portfolio of metabolically inert antifolate molecules consisting of CH-1504 and CH-4051, which are orally available molecules with anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Advisors' Opinion:

• [By Jon C. Ogg]

  Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is finding a serious victory from its hypotension drug. Shares hit a 52-week high — make that a three-year high — after the company confirmed an accelerated FDA approval of its Northera for the treatment of low blood pressure, following FDA panel backing just last month.

• [By John Udovich]

  The biotech roller-coaster continues for investors into 2014 with small cap Chelsea Therapeutics International Ltd (NASDAQ: CHTP) set to more than double when the market opens today, meaning its time to take a closer look at what in the world is going on with the stocks plus take a closer look at the performance of biotech peers like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

Top Life Sciences Companies To Watch For 2014: Velti plc(VELT)

Velti plc provides mobile marketing and advertising solutions for mobile operators, ad agencies, brands, and media groups. The company?s Mobile Marketing Platform (MMP) helps businesses to plan, execute, monitor, and measure mobile marketing or advertising campaigns on various digital delivery channels, including Internet sites, SMS and MMS, mobile TV, mobile communities, mobile applications, location-based services, and mobile social networking. Its MMP also helps in the creation of mobile Websites, portals, blogs, content, iPhone applications, branded games, and mobile widgets; and in the mobile marketing through mobile clubs, mobile content, contests, couponing, alerts and tips, photo/text to screen, green screen, and image remix applications. In addition, MMP offers Mobile CRM solutions that help in the creation and management of mobile communities, mobile broadcasts, member management, segment management, member rewards, multichannel registration, and advanced profil ing. It has operations in Europe, North America, the Middle East, and Asia. The company was founded in 2000 and is based in London, the United Kingdom.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 name that's quickly moving within range of triggering a big breakout trade is Velti (VELT), which provides mobile marketing and advertising technology solutions that enable brands, advertising agencies, and mobile operators to implement interactive and measurable campaigns by communicating with and engaging consumers via their mobile devices. This stock has been destroyed by the bears so far in 2013, with shares off sharply by 91%.

  If you take a look at the chart for Velti, you'll notice that this stock recently gapped down big from over $1 a share to 33 cents per share with monster downside volume. Following that gap down, shares of VELT have started to consolidate and move sideways between 33 cents per share on the downside and 44 cents per share on the upside. Shares of VELT are spiking sharply higher on Thursday above some near-term support at 35 cents per share. That move is pushing this stock within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.

  Market players should now look for long-biased trades in VELT if it manages to break out above some near-term overhead resistance at 44 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 2.02 million shares. If that breakout triggers soon, then VELT could easily explode higher and potentially re-test its gap down day high from August at 66 cents per share.

  Traders can look to buy VELT off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 35 cents to 33 cents per share. One can also buy VELT off strength once it clears 44 cents per share with volume and then simply use a stop that sits a comfortable percentage from your entry point.